National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/14/2022 release of VAERS data:

Found 3,619 cases where Vaccine is COVID19 and Symptom is COVID-19 and Patient Died

Government Disclaimer on use of this data



Case Details (Sorted by Age)

This is page 17 out of 362

Result pages: prev   8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26   next


VAERS ID: 1064480 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-18
Onset:2021-01-26
   Days after vaccination:8
Submitted: 0000-00-00
Entered: 2021-03-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Pneumonia, SARS-CoV-2 test
SMQs:, Eosinophilic pneumonia (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (narrow), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-02-04
   Days after onset: 9
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Below knee amputation
Allergies:
Diagnostic Lab Data: Test Date: 20210126; Test Name: SARS-CoV-2 test; Test Result: Positive
CDC Split Type: CZPFIZER INC2021190786

Write-up: Bilateral pneumonia; COVID-19; This is a spontaneous report from a contactable consumer downloaded from the Regulatory Authority-WEB. This is a report received from the regulatory authority report number is CZ-CZSUKL-21001001. An 88-year-old male patient received the first dose of the bnt162b2 (COMIRNATY), via an unspecified route of administration on 18Jan2021 at a single dose for COVID-19 immunization. The patient''s medical history included below knee amputation on 07Feb2020. Concomitant medications were not reported. On 26Jan2021, the patient experienced COVID-19 (death, hospitalization, medically significant, life threatening). On an unspecified date, the patient experienced bilateral pneumonia (death, hospitalization, medically significant). The patient underwent lab tests and procedures which included SARS-CoV-2 test: positive on 26Jan2021. The clinical outcome of the events: bilateral pneumonia and COVID-19, was fatal. The patient died on 04Feb2021 due to bilateral pneumonia and COVID-19. An autopsy was not performed. No follow-up attempts are possible; information about batch/lot number cannot be obtained. ; Reported Cause(s) of Death: Bilateral pneumonia; COVID-19


VAERS ID: 1065049 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-29
Onset:2021-02-06
   Days after vaccination:8
Submitted: 0000-00-00
Entered: 2021-03-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6134 / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, SARS-CoV-2 test
SMQs:, Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-12
   Days after onset: 6
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: MIDAZOLAM; MORFINE
Current Illness: COPD; Emphysema pulmonary
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210206; Test Name: COVID-19; Result Unstructured Data: Test Result:positive
CDC Split Type: NLPFIZER INC2021191175

Write-up: COVID-19; This is a spontaneous report received from a contactable physician, downloaded from the Regulatory Authority NL-LRB-00444454. A 90-year-old female patient received bnt162b2 (COMIRNATY) (Lot # EJ6134), via an unspecified route of administration at single dose on 29Jan2021 for covid-19 immunisation. Medical history included ongoing chronic obstructive pulmonary disease, ongoing emphysema. Concomitant medication included midazolam, morfine. The patient experienced Covid-19 on 06Feb2021 with fatal outcome. The patient died on 12Feb2021. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 06Feb2021. It was not reported if an autopsy was performed. The patient died at home using palliative sedation as a result of complications from Covid-19. Unknown if there was a relationship with vaccination with Comirnaty. Clinical course as follows: 5 days after vaccination, the patient experienced symptoms of a Covid-19 infection, 8 days after vaccinations the patient had a positive SARS COV 2 test and 14 days after vaccination the patient deceased with palliative sedation. The patient died of complications of a Covid-19 infection. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: complications of COVID19


VAERS ID: 1065211 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-19
Onset:2021-01-25
   Days after vaccination:6
Submitted: 0000-00-00
Entered: 2021-03-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EJ6795 / 1 LA / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, SARS-CoV-2 test
SMQs:, Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-11
   Days after onset: 17
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Anxiodepressive syndrome; Bedridden; Carcinoid tumour (vertex carcinoid, untreated); Cognitive disorder; COVID-19 virus test negative; Disease Parkinson''s; Starvation
Allergies:
Diagnostic Lab Data: Test Date: 20210118; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:negative; Test Date: 20210125; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:positive
CDC Split Type: FRPFIZER INC2021203245

Write-up: COVID-19; This is a spontaneous report from a contactable pharmacist downloaded from the Medicines Agency (MA) regulatory authority-WEB FR-AFSSAPS-LY20210735. A 90-years-old male patient received the first dose of bnt162b2 (COMIRNATY; Lot # EJ6795 ) vaccine , intramuscular in the left arm 19Jan2021 at SINGLE DOSE for covid-19 immunisation . Medical history included mixed anxiety and depressive disorder, cognitive disorder , Parkinson''s disease, starvation , carcinoid tumour (vertex carcinoid, untreated) , Sars-cov-2 test negative on 18Jan2021, bedridden . The patient''s concomitant medications were not reported. On 25Jan2021 during a systematic COVID-19 screening, the patient had a COVID PCR test positive: no symptoms presented to date. On 02Feb2021: the patient presented symptoms such as rapid breathing, fever. he was put under O2. His condition deteriorated rapidly, he presented with dehydration and a back pressure ulcer. On 05Feb2021 comfort care were implemented. On 11Feb2021 the patient died at 8 a.m. The cause of death was Covid-19. Follow up information cannot be obtained. The patient experienced covid-19 (covid-19) (death) on 25Jan2021. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 18Jan2021 , sars-cov-2 test: positive on 25Jan2021 . The action taken in response to the event(s) for bnt162b2 was not applicable. Therapeutic measures were taken as a result of covid-19 (covid-19). The patient died on 11Feb2021. It was not reported if an autopsy was performed.; Reported Cause(s) of Death: Covid-19


VAERS ID: 1065267 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-19
Onset:2021-01-25
   Days after vaccination:6
Submitted: 0000-00-00
Entered: 2021-03-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, SARS-CoV-2 test
SMQs:, Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-05
   Days after onset: 11
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Alzheimer''s disease; Memory loss; Comments: Patient has not had symptoms associated with COVID-19 Patient is not enrolled in clinical trial
Allergies:
Diagnostic Lab Data: Test Date: 20210125; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:Positive
CDC Split Type: GBPFIZER INC2021205310

Write-up: positive COVID-19 test; This is a spontaneous report from a contactable consumer received from the regulatory authority. Regulatory authority report number GB-MHRA-WEBCOVID-202102221318192820, Safety Report Unique Identifier GB-MHRA-ADR 24814558. An 84-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at single dose on 19Jan2021 for covid-19 immunisation . Medical history included amnesia, dementia Alzheimer''s type. Concomitant medications were not reported. The patient experienced positive Covid-19 test on 25Jan2021. The patient died on 05Feb2021. It was not reported if an autopsy was performed. The patient had not had symptoms associated with COVID-19. The patient was not enrolled in a clinical trial. The reporter stated that: "My father was ok leading up to the vaccine he was quiet and tired due to boredom of being locked away in a care home unable to see relatives frequently or go outside and live a normal life". No follow-up attempts possible; information regarding batch/lot cannot be obtained; No further information expected.; Reported Cause(s) of Death: COVID-19


VAERS ID: 1065274 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2020-12-16
Onset:2021-01-11
   Days after vaccination:26
Submitted: 0000-00-00
Entered: 2021-03-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Diarrhoea, Drug ineffective, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Pseudomembranous colitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Noninfectious diarrhoea (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-21
   Days after onset: 10
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: ALFUZOSIN; OMEPRAZOLE; PROPRANOLOL
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Colon cancer; Interstitial lung disease; Whipple''s disease; Comments: Patient is not enrolled in clinical trial
Allergies:
Diagnostic Lab Data: Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:Yes - Positive COVID-19 test
CDC Split Type: GBPFIZER INC2021210283

Write-up: patient was admitted to the hospital; drug ineffective; SARS-CoV-2 infection; This is a spontaneous report from a contactable Physician. This is a report received from the MHRA. Regulatory authority report number GB-MHRA-ADR 24820376, Safety Report Unique Identifier GB-MHRA-WEBCOVID-202102231206328040. An 85 years old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) on 16Dec2020 at single dose via an unspecified route of administration for COVID-19 immunization. Relevant medical history included Interstitial lung disease, colon cancer on Mar2008, Whipple''s disease. Concomitant medications included alfuzosin, omeprazole and propranolol. On an unspecified date patient had acute diarrhea and was admitted to the hospital. On 11 Jan2021 SARS-CoV-2 infection occurred. Vaccine breakthrough infection (as reported). SARS-CoV-2 test was positive on an unspecified date. On 21Jan2021 the patient died due to Covid 19. Outcome of reported acute diarrhea at time of death was unknown. It was unknown if an autopsy was performed. No follow-up attempts possible; information regarding batch/lot cannot be obtained; No further information expected.; Reported Cause(s) of Death: COVID-19


VAERS ID: 1065562 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Foreign  
Vaccinated:2021-01-13
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-03-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, General physical health deterioration, SARS-CoV-2 test positive
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-01-30
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: Nasopharyngeal pcr test; Test Result: Positive
CDC Split Type: BEPFIZER INC2021181924

Write-up: Drug ineffective; Nasopharyngeal pcr test on the 21st, which came back positive; Degradation of general condition; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB BE-FAMHP-DHH-N2021-76426, received from Regulatory Authority. An elderly patient of unspecified gender received BNT162B2 (COMIRNATY) via an unspecified route of administration on 13Jan2021 at single dose for COVID-19 immunisation. Medical history and concomitant mediations were unknown. The patient experienced COVID-19 virus test positive and degradation of general condition. The patient had nasopharyngeal pcr test on the 21st (unspecified date), which came back positive. The patient died on 30Jan2021. It was unknown if autopsy was performed. Outcome of the events was fatal. No follow-up attempts are possible, information on lot/batch number cannot be obtained.; Reported Cause(s) of Death: Drug ineffective; Nasopharyngeal pcr test on the 21st, which came back positive; degradation of general condition


VAERS ID: 1065567 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-01-13
Onset:2021-01-14
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-03-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL1491 / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Cerebrovascular accident, Communication disorder, Fatigue, Hypersomnia, Illness, SARS-CoV-2 test
SMQs:, Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Depression (excl suicide and self injury) (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-01-24
   Days after onset: 10
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Arterial hypertension; Arthrosis multiple; Diabetic nephropathy; Diabetic polyneuropathy; Diabetic retinopathy (bilateral); Dyslipidemia (on therapy with statin); Glaucoma; Hepatic steatosis; Hypoxic-ischemic encephalopathy; Ischaemic heart disease (dysrhythmic form); Osteoporosis postmenopausal; Penicillin allergy (swelling of the face); Psoriatic arthropathy; Recurrent urinary tract infection; Smoker (3-5 cigarettes / day); Vertebrogenic pain syndrome; Vestibulocerebellar syndrome (instability with repeated falls)
Preexisting Conditions: Medical History/Concurrent Conditions: Abscess (trochanter abscess l.dx. sepses etiologically MRSA); Age-related macular degeneration (practical blindness on right); Appendectomy; Bedridden (Before the vaccination, the patient was a lying patient, but she raised her hands and communicated); Cataract operation (bilaterally); Cholecystolithiasis; Dysfunction thyroid; Endarterectomy (bilaterally); Euthyroid goiter; Hysterectomy; Hysterosalpingo-oophorectomy (for myomatosis); Psoriasis vulgaris; Recurrent stroke (recurrent stroke with mild residual left-sided finding, last stroke 5/2014); Small intestinal resection (for volvulus with peritonitis in 2005 and for volvulus in 2009); Type II diabetes mellitus (now without therapy); Ulcerative colitis (relapse May2016)
Allergies:
Diagnostic Lab Data: Test Date: 20210117; Test Name: Covid-19 test; Result Unstructured Data: Test Result:positive antigen
CDC Split Type: CZPFIZER INC2021180953

Write-up: COVID-19/positive antigen Covid-19 test; became ill; Sleep excessive/still asleep/she was sleepy; tired; Communication disorder/stopped communicating by phone; suspected of having another stroke/Suspicion of cerebrovascular accident; This is a spontaneous report received from a contactable consumer, downloaded from the Medicines Agency (MA) regulatory authority CZ-CZSUKL-21001005. A 72-year-old female patient received the first dose of BNT162B2 (COMIRNATY, lot number EL1491) via Intramuscular on 13Jan2021 at single dose for COVID-19 immunisation. Medical history included: ischemic heart disease, dysrhythmic form, recurrent stroke with mild residual left-sided finding, last stroke May2014, endarterectomy bilaterally 1999, ongoing vascular and hypoxic encephalopathy, ongoing arterial hypertension, type 2 diabetes mellitus since 2006, now without therapy, ongoing diabetic nephropathy, ongoing diabetic polyneuropathy, ongoing diabetic retinopathy bilateral and age-related macular degeneration (practical blindness on right), ongoing dyslipidemia on statin therapy, thyroidopathy, goitre, effector, dysfunction thyroid, ulcerative colitis, relapse in May2016, small bowel resection for volvulus with peritonitis in 2005, cholecystolithiasis, ongoing hepatic steatosis, psoriasis vulgaris, ongoing psoriatic arthropathy, ongoing vertebrogenic algic polytopic syndrome, ongoing cerebello-vestibular syndrome, instability with repeated falls, ongoing polyarthrosis, ongoing postmenopausal osteoporosis, recurrent urinary tract infections, intestinal resection for volvulus in 2009, trochanter abscess l.dx. sepses etiologically MRSA, appendectomy, hysterectomy + adnexectomy/ hysterosalpingo-oophorectomy for myomatosis, cataract surgery bilaterally, ongoing glaucoma, allergies to penicillin (swelling of the face), smoker (3-5 cigarettes /day). Family history was insignificant. Before the vaccination, the patient was a lying patient, but she raised her hands and communicated. Concomitant medications were not reported. Previous vaccination included: against tetanus in Jan2017. It was reported the next day she stopped communicating by phone/ communication disorder. The patient was in a nursing home, from where the reporter had information that the patient was sleep excessive/still asleep. She didn''t even say hello to the phone and stopped moving. Before the vaccination, the patient was a lying patient, but she raised her hands and communicated. The reporter was suspected of having another stroke/suspicion of cerebrovascular accident. According to the reporter, Covid-19 disease was also added. The patient died on 24Jan2021. On 15Feb2021, the attending physician was called: added medical history of the patient. 48 hours after vaccination, the patient was monitored and no deterioration was observed. On 17Jan2021 the patient became ill and was very sleepy. An ambulance was called and the patient was hospitalized. On 16Feb2021, charge nurse was called: patient was alright at the time of vaccination. No marks of stroke or infection. She was cooperating, consciousness. On 15Jan2021 she was sleepy and tired. On 17Jan2021 she had positive antigen Covid-19 test. Many patients had similar symptoms and many of them had antigen Covid-19 positive test. Rales, normal saturation, normal physiological function. She was transferred to neurological department after nurse urging. A hospitalisation report was requested. On 24Jan2021 patient died. Outcome of event COVID-19/positive antigen Covid-19 test was fatal, for other events were not recovered. Autopsy was not indicated. And the reported cause of death was COVID-19/positive antigen Covid-19 test.; Reported Cause(s) of Death: COVID-19/positive antigen Covid-19 test


VAERS ID: 1065568 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-01
Onset:2021-02-08
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-03-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 2 - / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Condition aggravated, Eating disorder, Hyperphagia, Oxygen saturation, Pulmonary embolism, SARS-CoV-2 test, Vaccination failure, Vomiting
SMQs:, Acute pancreatitis (broad), Lack of efficacy/effect (narrow), Hyperglycaemia/new onset diabetes mellitus (broad), Embolic and thrombotic events, venous (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-09
   Days after onset: 1
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Thyroid disorder
Preexisting Conditions: Medical History/Concurrent Conditions: Varicose vein operation
Allergies:
Diagnostic Lab Data: Test Date: 202102; Test Name: O2 saturation; Test Result: 50 %; Test Date: 20210209; Test Name: COVID-19 PCR test; Test Result: Positive
CDC Split Type: CZPFIZER INC2021181088

Write-up: Pulmonary embolism; PCR Covid-19 positive; PCR Covid-19 positive; Vomiting; aggravated food intake; Eating disorder; Condition aggravated; This is a spontaneous report from a contactable consumer (patient) downloaded from the Regulatory Authority-CZSUKL-21001137. An 85-year-old female patient received bnt162b2 (COMIRNATY), 1st dose on 11Jan2021 and 2nd dose on 01Feb2021, both via intramuscular at single dose for COVID-19 immunisation. Medical history included ongoing thyroid disorder and patient was on therapy (psychotropic medicinal products and food supplements) and varicose vein operation. The patient''s concomitant medications were not reported. After 7 days after the 2nd dose, there were some adverse reaction: aggravated condition, vomiting, aggravated food intake, eating disorder, all on 08Feb2021. She was transferred to the hospital, where she was diagnosed with massive pulmonary embolism with saturation 50% on 08Feb2021. PCR Covid-19 was positive on 09Feb2021. PCR Covid-19 positive 09Feb2021. Patient died on 09Feb2021. The cause of death was reported as embolism lung. Autopsy was done. Autopsy results was not available and will be informed about autopsy results. No follow-up attempts possible. Batch/Lot numbers cannot be obtained.; Reported Cause(s) of Death: Embolism lung


VAERS ID: 1067874 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-02-04
Onset:2021-02-07
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2021-03-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 - / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Death, Oropharyngeal pain, Oxygen saturation, Oxygen saturation decreased, SARS-CoV-2 test
SMQs:, Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Acute central respiratory depression (broad), Respiratory failure (broad), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-12
   Days after onset: 5
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210211; Test Name: Oxygen saturation; Test Result: 79 %; Test Date: 20210208; Test Name: COVID-19 PCR test; Test Result: Positive ; Test Date: 20210210; Test Name: COVID-19 PCR test; Test Result: Positive
CDC Split Type: NLPFIZER INC2021199231

Write-up: death; COVID-19 positive; low oxygen saturation levels (79%); throat pain; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB NL-LRB-00446680 via Regulatory Authority. A 74-years-old female patient received first dose of BNT162B2 (COMIRNATY), via unknown route of administration on 04Feb2021 at single dose for COVID-19 immunisation. The patient medical history was not reported. The patient''s concomitant medications were not reported. The patient experienced death on 12Feb2021. It was also reported that COVID-19 positive caused patient death. Three days after vaccination on 07Feb2021, the patient had throat pain. 08Feb2021, COVID-19 PCR test performed and patient tested positive. On 10Feb2021, COVID-19 PCR test was positive. The patient was treated with 5L oxygen, but low oxygen saturation levels (79%) remained on 11Feb2021. Start morphine with restrained policy. On 12Feb2021, the patient deceased. Outcome of the event other event was unknown. It was unknown if an autopsy was done or not. No follow-up attempts are possible; information on batch/lot number cannot be obtained.; Reporter''s Comments: BioNTech / Pfizer vaccine (Comirnaty) Past drug therapy BioNTech / Pfizer vaccine (Comirnaty): no Death Additional information ADR: 04Feb vaccination. 07Feb arise sore throat. 08Feb Covid-19 PCR test performed. 10Feb result: positive. 11Feb low saturation (79%) despite 5 liters of oxygen. Start morphine with restrained policy. 12Feb death BSN available: yes COVID19 Previous COVID-19 infection: disease symptoms: hospitalization; Reported Cause(s) of Death: Covid 19 positive; death


VAERS ID: 1069329 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2021-01-15
Onset:2021-01-28
   Days after vaccination:13
Submitted: 0000-00-00
Entered: 2021-03-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL1491 / 1 - / -

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test
SMQs:, Lack of efficacy/effect (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-02-16
   Days after onset: 19
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Coronary heart disease; COVID-19; Dementia; Polyneuropathy; Renal insufficiency (NINS)
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Date: 20210128; Test Name: COVID-19 PCR test; Test Result: Positive
CDC Split Type: ATPFIZER INC2021221804

Write-up: COVID-19 post Infection/COVID-19 respiratory infection/COVID-19 PCR test on 28Jan2021; COVID-19 post Infection/COVID-19 respiratory infection/COVID-19 PCR test on 28Jan2021; This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB via Regulatory Authority with Regulatory Authority number: AT-BASGAGES-2021-07099. An 88-year-old male patient received first dose of bnt162b2 (COMIRNATY, Solution for injection, batch/lot number: EL1491), via an unspecified route of administration on 15Jan2021 (at unspecified age) at single dose for covid-19 immunisation. Medical history included ongoing Renal insufficiency (NINS), ongoing Polyneuropathy, ongoing COVID-19, ongoing Coronary heart disease, ongoing Dementia. The patient''s weight was not reported, and height was not reported. No concomitant medication reported. "A possible connection between deaths and COVID vaccinations carried out shortly before is suspected. The people were all vaccinated against COVID-19 on 15Jan2021 (1st vaccination with Comirnaty, batch EL1491), tested positive 4 to 13 days later (one patient 32nd Days later) and died 10 to 20 days after the vaccination (said patient 37 days later). A comparable number of deaths has not occurred in the nursing home in recent years." COVID infection has been circulating in the home since January. All 12/14 deceased have been tested positive for Sars-CoV2 by PCR. The patient in this NW report also tested positive for Sars-CoV2 by PCR (28Jan2021), then died of his COVID infection at the home on 16Feb2021. On Jan2021 the patient experienced COVID-19 death. The patient''s outcome was fatal for COVID-19. The patient died on 16Feb2021 from COVID-19 respiratory infection. The patient underwent lab tests and procedures which included COVID-19 PCR test: Positive on 28Jan2021. The patient died on 16Feb2021. An autopsy was not performed. No follow-up attempts possible. No further information expected.; Reported Cause(s) of Death: COVID-19 respiratory infection/COVID-19 post Infection


Result pages: prev   8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=17&ESORT=AGE&SYMPTOMS=COVID-19&VAX=COVID19&DIED=Yes


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166